Clinical monitoring VRC 608- ebola
Ended Awarded Last action
- Contract number
- 75N93018F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $48,205
Award facts
- Opportunity
-
- NIHAO2017058 Solicitation number
- Vaccine Research Center Clinical Monitoring Initiative Award Notice · Posted Dec 8, 2016
- Vaccine Research Center Clinical Site Monitoring Services Initiative Award Notice · Posted Nov 17, 2016
- Contract value 100% obligated
- $48,204.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$12,762 | |
| Original award | $60,967 |
About this award
The National Institute of Diabetes and Digestive and Kidney Diseases issued a delivery order to The Emmes Company, LLC on June 26, 2018, under the VRC Clinical Monitoring Initiative 2017–2024 for clinical monitoring of an Ebola vaccine research initiative with a ceiling value of $48,204.93.
The VRC Clinical Monitoring Initiative is a parent IDIQ supporting clinical research coordination and monitoring services. The order is set aside for Total Small Business. Work is performed in Rockville, Maryland, with an ultimate completion date of July 1, 2020. Pricing is Cost Plus Fixed Fee.
Quick answers
Who was awarded contract 75N93018F00002?
75N93018F00002 was awarded to The Emmes Company, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 26, 2018.
How much is contract 75N93018F00002 worth?
The government has obligated $48,205 on 75N93018F00002.
Which agency awarded contract 75N93018F00002?
National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded 75N93018F00002, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).
Is contract 75N93018F00002 an order under another contract?
Yes. 75N93018F00002 is a delivery order under HHSN272201700051I, an indefinite delivery contract, on VRC Clinical Monitoring Initiative 2017-2024.
Was contract 75N93018F00002 competed?
The extent of competition for 75N93018F00002 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award